Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

SELL
$2.16 - $3.33 $5,985 - $9,227
-2,771 Reduced 95.95%
117 $0
Q2 2022

Jul 19, 2022

BUY
$1.94 - $4.02 $5,602 - $11,609
2,888 New
2,888 $7,000
Q1 2022

May 03, 2022

SELL
$3.19 - $6.17 $9,436 - $18,250
-2,958 Closed
0 $0
Q3 2021

Oct 25, 2021

BUY
$7.07 - $14.84 $20,913 - $43,896
2,958 New
2,958 $25,000

Others Institutions Holding INDP

About Indaptus Therapeutics, Inc.


  • Ticker INDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,258,600
  • Market Cap $6.94M
  • Description
  • Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...
More about INDP
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.